Mangiferin monosodium salt (MGM) augments GPX4 and FSP1/CoQ10 axis expression, suppresses lipid drivers promoting renal prolapse mediated by ACSL4, mitigates ROS and lipid accumulation, and inhibits ferroptosis in DKD rats. This evidence concerns the gene GPX4 and diabetic kidney disease.